Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/10/22 17:03 | 12/30/21 | WINT | Health | BioPrd | Biological Products, (No Diag | Bioengine Capital Inc. | F5 | T | S.d | -1,983 | 1.60 | 0 | -1,239 | -100 | 0 | D | |||||||||||||||
12/21/10 15:22 | 12/17/10 | DSCO | Health | BioPrd | Biological Products, (No Diag | Lopez David L | PA | O | EVP,Lega | S | -4 | 0.2116 | 0 | -17 | -5 | 310 | M | -83 | -69 | -17 | -13 | -13 | 0 | 11 | 5 | 0 | 31 | 6 | -36 | -32 | -50 |
6/7/05 17:03 | 6/3/05 | DSCO | Health | BioPrd | Biological Products, (No Diag | Segal Robert-Md | PA | O | SVP,Chie | S.d | -102 | 6.82 | 0 | -15 | -77 | 4 | D | 35 | -34 | -2 | 32 | 13 | 5 | -1 | -5 | -1 | 0 | 10 | -8 | 5 | -70 |
5/31/05 09:53 | 5/26/05 | DSCO | Health | BioPrd | Biological Products, (No Diag | Niven Ralph | PA | O | SVP-Prec | S.d | -89 | 7.08 | 0 | -13 | -13 | 88 | D | 85 | -34 | 0 | 22 | 17 | 18 | 10 | 7 | -1 | -5 | 3 | -10 | -2 | -69 |
5/26/05 17:23 | 5/24/05 | DSCO | Health | BioPrd | Biological Products, (No Diag | Niven Ralph | PA | O | SVP- Pre | S.dm | -148 | 6.68 | 0 | -22 | -20 | 88 | D | 81 | -33 | -4 | 14 | 18 | 12 | 6 | 4 | 1 | -1 | 2 | -7 | 0 | -70 |
5/24/05 17:19 | 5/23/05 | DSCO | Health | BioPrd | Biological Products, (No Diag | Niven Ralph | PA | O | SVP- Pre | S.d | -38 | 6.66 | 0 | -6 | -6 | 88 | D | 78 | -35 | -9 | 11 | 4 | 13 | 4 | 0 | 3 | 6 | 12 | -4 | 7 | -70 |
5/13/05 15:47 | 5/11/05 | DSCO | Health | BioPrd | Biological Products, (No Diag | Niven Ralph | PA | O | Sr.VP Pr | S.d | -40 | 6.41 | 0 | -6 | -41 | 9 | D | 87 | -37 | -10 | 10 | 11 | 4 | 9 | 3 | 1 | 5 | 8 | 15 | 16 | -59 |
12/13/04 17:52 | 12/10/04 | DSCO | Health | BioPrd | Biological Products, (No Diag | Niven Ralph | PA | O | SVP Prec | S | -83 | 8.28 | 0 | -10 | -53 | 9 | D | -6 | -9 | -1 | 27 | 22 | 25 | 6 | -1 | -1 | -21 | -42 | -28 | -23 | |
6/2/04 14:09 | 5/28/04 | DSCO | Health | BioPrd | Biological Products, (No Diag | Cooper John G | PA | O | EVP,CFO | S | -108 | 10.78 | 0 | -10 | -47 | 11 | D | 167 | 29 | -10 | -8 | 12 | 10 | 4 | -1 | -5 | -17 | -28 | -37 | -35 | |
6/2/04 14:05 | 5/28/04 | DSCO | Health | BioPrd | Biological Products, (No Diag | Lopez David L | O | SVP,Lega | S.d | -108 | 10.84 | 0 | -10 | -73 | 4 | D | 167 | 29 | -10 | -8 | 12 | 10 | 4 | -1 | -5 | -17 | -28 | -37 | -35 | ||
5/28/04 11:42 | 5/27/04 | DSCO | Health | BioPrd | Biological Products, (No Diag | Cooper John G | PA | O | EVP,CFO | S.d | -210 | 10.51 | 0 | -20 | -48 | 21 | D | 181 | 34 | -10 | -11 | 5 | 8 | 8 | 1 | -5 | -11 | -26 | -34 | -34 | |
4/28/04 18:03 | 4/26/04 | DSCO | Health | BioPrd | Biological Products, (No Diag | Zodda Deni M Phd | PA | O | Senior V | S.d | -307 | 12.81 | 0 | -24 | -79 | 6 | D | 372 | 81 | 2 | 5 | 0 | 2 | 2 | -3 | -6 | -12 | -39 | -43 | -49 | |
4/14/04 20:29 | 4/5/04 | DSCO | Health | BioPrd | Biological Products, (No Diag | Davis Cynthia | PA | O | VP,Contr | S.ad | -189 | 12.61 | 0 | -15 | -42 | 21 | D | 607 | 66 | 15 | 1 | 19 | -1 | 0 | 1 | 0 | -17 | -27 | -42 | -48 | |
4/12/04 17:37 | 4/8/04 | DSCO | Health | BioPrd | Biological Products, (No Diag | Davis Cynthia | PA | O | VP,Contr | S.d | -189 | 12.61 | 0 | -15 | -42 | 21 | D | 588 | 60 | 20 | 4 | 8 | 9 | -2 | -1 | -3 | -24 | -29 | -50 | -51 | |
4/7/04 17:27 | 4/6/04 | DSCO | Health | BioPrd | Biological Products, (No Diag | McDade Herbert H | PA | D | S.d | -249 | 12.43 | 0 | -20 | -100 | 0 | D | 677 | 73 | 22 | 10 | 6 | 11 | -1 | 0 | -3 | -12 | -29 | -44 | -54 | ||
8/18/03 16:57 | 8/14/03 | DSCO | Health | BioPrd | Biological Products, (No Diag | McDade Herbert H | PA | D | S.dm | -245 | 7.30 | 0 | -34 | -85 | 6 | D | 265 | 116 | 4 | 0 | -6 | -1 | 0 | 0 | 12 | -3 | 55 | 5 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |